Elanco Animal Health (ELAN) | Stock Overview & Key Data
Elanco Animal Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $37.61 on September 24, 2018
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Elanco Animal Health
ELAN
|
11.18B Large-cap | 2.58% | 22.31% | 3.80% | 11.94% | 7.86% | 75.02% | 133.08% | -30.33% | -29.12% | -29.12% | -29.12% |
|
Zoetis
ZTS
|
49.75B Large-cap | 0.16% | 3.42% | -31.08% | -32.94% | -36.81% | -51.58% | -53.40% | -57.08% | 71.34% | 156.59% | 156.59% |
|
Haleon Plc - ADR
HLN
|
42.40B Large-cap | 2.02% | 1.23% | -13.29% | -7.73% | -9.30% | -16.01% | 8.43% | 23.21% | 23.21% | 23.21% | 23.21% |
|
United Therapeutics
UTHR
|
25.11B Large-cap | 0.90% | -3.34% | 2.86% | 9.85% | 10.64% | 92.68% | 137.11% | 205.88% | 434.68% | 903.79% | 2,026.01% |
|
Viatris
VTRS
|
16.99B Large-cap | 2.45% | -0.97% | 20.80% | 39.97% | 30.98% | 84.75% | 60.16% | 15.57% | -63.39% | -26.00% | -21.07% |
|
Intra-Cellular
ITCI
|
14.05B Large-cap | N/A | N/A | N/A | N/A | N/A | 92.68% | 104.13% | 700.67% | 449.92% | 632.61% | 632.61% |
Ownership & Short Interest
Calculate Your Elanco Animal Health Investment Returns
Long-Term Investment Performance Analysis
Elanco Animal Health stock price in Sep 2018 was $34.10, A $1,000.00 lump sum investment in Elanco Animal Health made 7 years ago would be worth approximately $712.32 today, representing a negative return of -28.77%. This translates to an annualized return (CAGR) of -4.29%.
7 Years 8 Months Investment Scenario (Sep 2018 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ELAN's 52-week high and low?
- In the last 52 weeks, Elanco Animal Health reached a high of $27.72 (on February 25, 2026) and a low of $13.16 (on June 23, 2025).
- What is the market cap and P/E ratio for ELAN?
- Curious about Elanco Animal Health's size and valuation? Its market capitalization stands at 11.18B. When it comes to valuation, the P/E ratio (trailing twelve months) is 377.14, and the forward P/E (looking ahead) is 19.35.
- Does ELAN pay dividends? If so, what's the yield?
- As for dividends, Elanco Animal Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Elanco Animal Health's main competitors or similar companies to consider before investing?
When looking at Elanco Animal Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS49.75B Healthcare Drug Manufacturers - Specialty & Generic -51.58% -53.40% Haleon Plc - ADR
HLN42.40B Healthcare Drug Manufacturers - Specialty & Generic -16.01% 8.43% United Therapeutics
UTHR25.11B Healthcare Drug Manufacturers - Specialty & Generic 92.68% 137.11% Viatris
VTRS16.99B Healthcare Drug Manufacturers - Specialty & Generic 84.75% 60.16% Intra-Cellular
ITCI14.05B Healthcare Drug Manufacturers - Specialty & Generic 92.68% 104.13% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Elanco Animal Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Elanco Animal Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -3.67%, the Debt to Equity ratio from the most recent quarter is 67.89, and its Gross Profit Margin stands at 51.49%.
- What is the recent revenue and earnings growth for ELAN?
- Looking at Elanco Animal Health's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.20%, and quarterly earnings saw a YoY growth of 12.16%.
- How much of ELAN stock is held by insiders and institutions?
- Wondering who owns Elanco Animal Health stock? Company insiders (like executives and directors) hold about 1.19% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 109.45%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.